Dongning Lu

Papers

Total Citations

H-Index

About

Dr. Dongning Lu is a pioneering urologic surgeon whose research focuses on advancing minimally invasive techniques for renal cancer treatment, particularly through the integration of interventional radiology and robotic surgery. His most cited work, a 2023 study on superselective transarterial embolization (STE) in zero ischaemia robotic-assisted laparoscopic partial nephrectomy (RALPN), demonstrates a major contribution to nephron-sparing surgery. By preoperatively embolizing renal tumors, Dr. Lu’s approach eliminates the need for renal artery clamping during surgery, thereby preserving kidney function while maintaining oncologic control. This innovative technique, validated in a cohort of 32 T1 renal cancer patients, has garnered 4 citations and represents a significant step toward safer, bloodless partial nephrectomy. Dr. Lu’s work bridges interventional radiology and robotic surgery, offering a paradigm shift in how urologists approach kidney tumors. His research not only enhances surgical precision but also reduces ischemic injury, improving long-term renal outcomes for patients. As a rising authority in zero-ischaemia techniques, Dr. Lu continues to shape the future of urologic oncology, inspiring further investigation into combined endovascular and robotic strategies.